Global Blood Plasma Fractionation Market Growth 2022-2028
The global market for Blood Plasma Fractionation is estimated to increase from $ 27700 million in 2021 to reach $ 47220 million by 2028, exhibiting a CAGR of 7.9% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Blood Plasma Fractionation players cover Takeda, CSL, Grifols, Octapharma and Kedrion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Blood Plasma Fractionation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Blood Plasma Fractionation market, with both quantitative and qualitative data, to help readers understand how the Blood Plasma Fractionation market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Blood Plasma Fractionation market and forecasts the market size by Type (Immune Globulin, Coagulation Factor and Albumin), by Application (Hospital, Retail Pharmacy and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Immune Globulin
Coagulation Factor
Albumin
Other
Segmentation by application
Hospital
Retail Pharmacy
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Chapter Introduction
Chapter 1: Scope of Blood Plasma Fractionation, Research Methodology, etc.
Chapter 2: Executive Summary, global Blood Plasma Fractionation market size (sales and revenue) and CAGR, Blood Plasma Fractionation market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Blood Plasma Fractionation sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Blood Plasma Fractionation sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Blood Plasma Fractionation market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.
Chapter 14: Research Findings and Conclusion
The APAC Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Blood Plasma Fractionation market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Blood Plasma Fractionation players cover Takeda, CSL, Grifols, Octapharma and Kedrion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Blood Plasma Fractionation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Blood Plasma Fractionation market, with both quantitative and qualitative data, to help readers understand how the Blood Plasma Fractionation market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Blood Plasma Fractionation market and forecasts the market size by Type (Immune Globulin, Coagulation Factor and Albumin), by Application (Hospital, Retail Pharmacy and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Immune Globulin
Coagulation Factor
Albumin
Other
Segmentation by application
Hospital
Retail Pharmacy
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Chapter Introduction
Chapter 1: Scope of Blood Plasma Fractionation, Research Methodology, etc.
Chapter 2: Executive Summary, global Blood Plasma Fractionation market size (sales and revenue) and CAGR, Blood Plasma Fractionation market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Blood Plasma Fractionation sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Blood Plasma Fractionation sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Blood Plasma Fractionation market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.
Chapter 14: Research Findings and Conclusion
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
